<DOC>
	<DOCNO>NCT02036710</DOCNO>
	<brief_summary>Background : Physicians unify , scientifically test theory causation obesity comorbidities , explanation mechanic metabolic/bariatric surgery procedure . Integral proffer hypothesis action hormone glucagon-like peptide ( GLP-1 ) , peptide YY ( PYY ) , leptin . Study objective : To obtain blood level GLP-1 , PYY , leptin stimulation terminal ileum cecum static infusion food hydrolysate morbidly obese patient undergo duodenal switch procedure . Methods : Plasma level GLP-1 , PYY , leptin obtain 0 , 30 , 60 , 90 , 120 minute instillation 240 ml food hydrolysate ileum cecum .</brief_summary>
	<brief_title>Location GLP-1 Release</brief_title>
	<detailed_description />
	<criteria>Any patient qualify approve bariatric surgery elect undergo open duodenal switch procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>GLP-1</keyword>
	<keyword>PYY</keyword>
	<keyword>Leptin</keyword>
	<keyword>Duodenal Switch</keyword>
</DOC>